Monday, January 20, 2025 2:38:43 PM
And the output is 28 cents! ;)
ChatGPT says this:
Let's calculate the loss and opportunity cost for an investment of $100,000 in January 2015 (10 year) for NWBO compared to Apple, Microsoft, and Alphabet:
NWBO Investment
Percentage Loss: -94.4%
Investment Value in January 2025:
100,000×(1-0.944)=100,000×0.056=5,600
Loss:
100,000-5,600=94,400
Apple Investment
Percentage Gain: +781.2%
Investment Value in January 2025:
100,000×(1+7.812)=100,000×8.812=881,200
Opportunity Cost:
881,200-5,600=875,600
Microsoft Investment
Percentage Gain: +813.9%
Investment Value in January 2025:
100,000×(1+8.139)=100,000×9.139=913,900
Opportunity Cost:
913,900-5,600=908,300
Alphabet Investment
Percentage Gain: +272.7%
Investment Value in January 2025:
100,000×(1+2.727)=100,000×3.727=372,700
Opportunity Cost:
372,700-5,600=367,100
Summary
Investment Final Value Loss/Opportunity Cost
NWBO $5,600 Loss: ($94,400)
Apple $881,200 Opp cost: $875,600
Microsoft $913,900 Opp Cost: $908,300
Alphabet $372,700 Opp Cost: $367,100
ChatGPT says this:
Let's calculate the loss and opportunity cost for an investment of $100,000 in January 2015 (10 year) for NWBO compared to Apple, Microsoft, and Alphabet:
NWBO Investment
Percentage Loss: -94.4%
Investment Value in January 2025:
100,000×(1-0.944)=100,000×0.056=5,600
Loss:
100,000-5,600=94,400
Apple Investment
Percentage Gain: +781.2%
Investment Value in January 2025:
100,000×(1+7.812)=100,000×8.812=881,200
Opportunity Cost:
881,200-5,600=875,600
Microsoft Investment
Percentage Gain: +813.9%
Investment Value in January 2025:
100,000×(1+8.139)=100,000×9.139=913,900
Opportunity Cost:
913,900-5,600=908,300
Alphabet Investment
Percentage Gain: +272.7%
Investment Value in January 2025:
100,000×(1+2.727)=100,000×3.727=372,700
Opportunity Cost:
372,700-5,600=367,100
Summary
Investment Final Value Loss/Opportunity Cost
NWBO $5,600 Loss: ($94,400)
Apple $881,200 Opp cost: $875,600
Microsoft $913,900 Opp Cost: $908,300
Alphabet $372,700 Opp Cost: $367,100
Recent NWBO News
- How Advanced Drug Delivery Could Improve Existing Cancer Treatments • GlobeNewswire Inc. • 06/01/2026 12:30:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
